We are once again asking you to leak us some documents!
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. First, we delve into the fallout over the FTC's move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer's downbeat future, Vertex Pharmaceuticals' next big thing, and a newly minted biotech VC with a very famous name. Listen Now Subscribe to the podcast to never miss an episode Visit the archive to see past episodes |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments